Publication | Open Access
The novel vasopressin receptor (V1aR) antagonist SRX246 reduces anxiety in an experimental model in humans: a randomized proof-of-concept study
34
Citations
56
References
2021
Year
Experimental PsychopathologyAntagonist Srx246PsychoneuroimmunologyStress HormonePsychiatryBehavioral NeuroscienceNovel Vasopressin ReceptorAffective NeuroscienceDepressionPsychopharmacologyNeuropharmacologyPsychologySocial SciencesNeuroscienceBiological PsychiatryMedicinePsychopathologyExperimental Model
| Year | Citations | |
|---|---|---|
Page 1
Page 1